Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Kjekshus

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
European Journal of Heart Failure|December 24, 2015
Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fractionKevin Damman, John Kjekshus, John Wikstrand, et al.
Cardiac Electrophysiology Review|January 24, 2004
How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF)John Wikstrand, Hans Wedel, Jalal Ghali, et al.
Journal of the American College of Cardiology|March 7, 2006
A protective anti-inflammatory phenotype in high-risk individuals who do not develop coronary artery diseaseTorbjørn Holm, Thor Ueland, Bente Halvorsen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2013
Atherosclerotic lesions in lymphoma survivors treated with radiotherapyTorgeir Wethal, Bård Nedregaard, Rune Andersen, et al.
The International Journal of Cardiovascular Imaging|March 20, 2015
Sensitive cardiac troponins and N-terminal pro-B-type natriuretic peptide in stable coronary artery disease: correlation with left ventricular function as assessed by myocardial strainMarit Kristine Smedsrud, Jørgen Gravning, Torbjørn Omland, et al.
American Heart Journal|April 30, 2013
Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosisJørgen Gravning, Marit Kristine Smedsrud, Torbjørn Omland, et al.
Clinical Cardiology|October 12, 2002
Inflammatory predictors of mortality in the Scandinavian Simvastatin Survival StudyFilippo Crea, Claudia Monaco, Gaetano A Lanza, et al.
Journal of Cardiac Failure|December 3, 2014
Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trialThor Ueland, Pål Aukrust, Ståle H Nymo, et al.
European Journal of Heart Failure|October 18, 2005
A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristicsJohn Kjekshus, Peter Dunselman, Malin Blideskog, et al.
American Heart Journal|December 1, 2012
The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)Lars Gullestad, Thor Ueland, John Kjekshus, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
European Journal of Heart Failure|December 24, 2015
Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fractionKevin Damman, John Kjekshus, John Wikstrand, et al.
Cardiac Electrophysiology Review|January 24, 2004
How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF)John Wikstrand, Hans Wedel, Jalal Ghali, et al.
Journal of the American College of Cardiology|March 7, 2006
A protective anti-inflammatory phenotype in high-risk individuals who do not develop coronary artery diseaseTorbjørn Holm, Thor Ueland, Bente Halvorsen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2013
Atherosclerotic lesions in lymphoma survivors treated with radiotherapyTorgeir Wethal, Bård Nedregaard, Rune Andersen, et al.
The International Journal of Cardiovascular Imaging|March 20, 2015
Sensitive cardiac troponins and N-terminal pro-B-type natriuretic peptide in stable coronary artery disease: correlation with left ventricular function as assessed by myocardial strainMarit Kristine Smedsrud, Jørgen Gravning, Torbjørn Omland, et al.
American Heart Journal|April 30, 2013
Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosisJørgen Gravning, Marit Kristine Smedsrud, Torbjørn Omland, et al.
Clinical Cardiology|October 12, 2002
Inflammatory predictors of mortality in the Scandinavian Simvastatin Survival StudyFilippo Crea, Claudia Monaco, Gaetano A Lanza, et al.
Journal of Cardiac Failure|December 3, 2014
Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trialThor Ueland, Pål Aukrust, Ståle H Nymo, et al.
European Journal of Heart Failure|October 18, 2005
A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristicsJohn Kjekshus, Peter Dunselman, Malin Blideskog, et al.
American Heart Journal|December 1, 2012
The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)Lars Gullestad, Thor Ueland, John Kjekshus, et al.
Pageof 12